Phytocannabinoids
CBD, CBG, CBC, CBN, and THCV produced via precision fermentation. No crop extraction, no harvest seasonality.
100+ compounds generated
AlkaloidsCannabinoidsPeptidesDesigned analogs
Every molecule CB Therapeutics produces travels the same loop. Each round sharpens titer, purity, and consistency, until the compound reaches what the program needs.
Every plan starts from a target compound. Phylogenomic and proteomic search surfaces the enzyme candidates; retrosynthetic work wires them into a coherent pathway.
One platform, eight compound classes. Phytocannabinoids, terpenes, tryptamines, rare alkaloids, ergolines, peptides, plus novel analog tracks for tryptamines and cannabinoids. The same biosynthetic logic runs across all of them.
CBD, CBG, CBC, CBN, and THCV produced via precision fermentation. No crop extraction, no harvest seasonality.
Novel chemical variants designed through enzyme engineering. Not naturally occurring, purpose-built for target profiles.
Geraniol, linalool, myrcene and the full aromatic palette. Fermentation-derived at consistent composition.
Baeocystin, 5-HTP, and the broader tryptamine class. Pathway runs end-to-end on engineered yeast for neuropsychiatric research.
Designed-novel compounds inspired by natural tryptamine scaffolds. New structural space for mental health applications.
Mitragynine, ergolines, and MIA pathway intermediates from Voacanga and Catharanthus sources. Rare alkaloids outside the tryptamine family.
Animal-free casein, collagen analogs, fats, and vitamins. Identical function, fundamentally different origin.
Yeast-derived colorants, flavors, and aromas. Functional food ingredients built from the same biosynthetic stack.
Compounds for mental health, non-opioid pain, and healthy aging. Precision fermentation. Carlsbad, CA.
Four brand introduction reels: CBT, TryptageniX, Aevora, and Korvane.
Eight granted US patents span the precision fermentation platform: yeast strains, biosynthetic pathways, downstream chemistry, and enzyme and gene mining. More applications pending.
Program launches, talks, and features. Inbound press welcome at info@cbthera.com.

“A cleaner question for kratom-class pain biology.”

“Animal-free by construction. Standardized by design.”

“Every run teaches the next one.”
Recent government and industry moves in mental health therapeutics, peptides, non-opioid pain, and precision fermentation.
CBT is open to partnerships across pharma, wellness, and food-tech, wherever precision fermentation fits the supply chain. We collaborate with research institutions on biosynthesis and enzyme engineering. And if you're a scientist operating at the top of your field, we want to hear from you.